True Wealth Design, LLC Prelude Therapeutics Inc Transaction History
True Wealth Design, LLC
- $263 Billion
- Q1 2025
A detailed history of True Wealth Design, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, True Wealth Design, LLC holds 10 shares of PRLD stock, worth $9. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$9% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
56Shares Held
28.3MCall Options Held
23.9KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$10 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$9.31 Million0.09% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$983,4020.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$928,4670.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD976KShares$898,0550.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $33.5M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...